Free Trial

Cognex (NASDAQ:CGNX) EVP Sells $90,090.00 in Stock

Cognex logo with Computer and Technology background

Key Points

  • Cognex EVP Sheila Marie Dipalma sold 2,002 shares of stock for a total of $90,090, representing an 18.92% decrease in her ownership.
  • The company's recent earnings report showed $0.25 EPS, exceeding analysts’ expectations of $0.23, with revenue increasing by 4.2% year-over-year.
  • Cognex has a current market capitalization of $7.49 billion, with stock analysts giving it a consensus rating of "Moderate Buy".
  • Five stocks we like better than Cognex.

Cognex Corporation (NASDAQ:CGNX - Get Free Report) EVP Sheila Marie Dipalma sold 2,002 shares of Cognex stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the sale, the executive vice president directly owned 8,582 shares of the company's stock, valued at $386,190. This trade represents a 18.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Sheila Marie Dipalma also recently made the following trade(s):

  • On Monday, September 8th, Sheila Marie Dipalma sold 2,000 shares of Cognex stock. The stock was sold at an average price of $45.03, for a total value of $90,060.00.

Cognex Price Performance

Shares of CGNX traded down $0.33 during midday trading on Monday, reaching $44.61. 1,723,639 shares of the stock were exchanged, compared to its average volume of 2,094,199. The business's 50-day moving average price is $38.59 and its 200 day moving average price is $32.64. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $45.23. The company has a market capitalization of $7.49 billion, a price-to-earnings ratio of 62.83 and a beta of 1.50.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The business had revenue of $249.09 million for the quarter, compared to analysts' expectations of $246.70 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business's revenue was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, equities research analysts expect that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were given a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex's payout ratio is 45.07%.

Analyst Ratings Changes

CGNX has been the topic of several recent research reports. DA Davidson boosted their price target on Cognex from $32.00 to $35.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Needham & Company LLC boosted their price target on Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Robert W. Baird upped their target price on Cognex from $30.00 to $32.00 and gave the company a "neutral" rating in a research note on Monday, June 16th. KeyCorp raised Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target on the stock in a research note on Friday, August 1st. Finally, Citigroup reissued a "neutral" rating and set a $37.00 price target (up previously from $30.00) on shares of Cognex in a research note on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Cognex currently has a consensus rating of "Moderate Buy" and an average target price of $42.31.

Get Our Latest Stock Analysis on CGNX

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Geneos Wealth Management Inc. increased its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after acquiring an additional 736 shares during the period. Farther Finance Advisors LLC grew its position in Cognex by 439.4% in the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock worth $29,000 after buying an additional 791 shares during the last quarter. Penserra Capital Management LLC acquired a new position in Cognex in the second quarter worth approximately $29,000. TD Waterhouse Canada Inc. acquired a new position in Cognex in the second quarter worth approximately $29,000. Finally, GAMMA Investing LLC grew its position in Cognex by 155.3% in the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock worth $32,000 after buying an additional 646 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex Company Profile

(Get Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.